SamaCare

Overview
Activities
News
Hospital Management?
Product stageSegments
Expansion
?
Clinical operations and workflow management
?

SamaCare is a cloud-based workflow automation platform that helps medical practices streamline administrative processes for specialty drugs, particularly prior authorizations, enrollment, and benefit verification. The company's platform enables providers to digitize and automate the traditionally manual and paper-heavy prior authorization process, reducing administrative burdens that can harm patient care, drive up costs, and frustrate healthcare providers.

SamaCare's technology allows medical practices to unify submission, tracking, and management of prior authorizations across all payers and plans through a single portal. Providers can automatically track the status of submitted prior authorizations, receive regular reporting with metrics like average resolution times, and avoid unnecessary treatment delays or rescheduling. As of June 2022, over 2,300 prescribers utilized SamaCare's platform.

Additionally, SamaCare partners with pharmaceutical manufacturers to provide aggregate insights on barriers to access and empower their market access teams at the point of care. The company offers premium services and data analytics to help pharmaceutical brands improve access to therapy.

SamaCare initially focused on retina practices within ophthalmology but has since expanded to oncology, rheumatology, neurology, and ambulatory infusion centers, accounting for over USD 20 billion in annual specialty drug spend as of June 2022. In May 2024, SamaCare secured a USD 17 million Series B investment led by Questa Capital to build a comprehensive "Script-to-Therapy Operating System" that enhances the platform's capabilities beyond prior authorizations, enabling seamless digital experiences across the entire post-prescription workflow.

Key customers and partnerships

In March 2023, SamaCare announced a partnership with AmerisourceBergen Specialty GPOs to offer its prior authorization platform to specialty physician practices across oncology, retina, rheumatology, and neurology. The collaboration solidified SamaCare's position as a market leader in prior authorization management for medical benefits, further empowering the company to realize its mission of making life-changing treatments available to patients at the moment of need.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
149 NEW MONTGOMERY STREET 4TH FLOOR San Francisco CA USA
Founded year:
2018
Employees:
101-250
IPO status:
Private
Total funding:
USD 34.8 mn
Last Funding:
USD 17.0 mn (Series B; May 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.